Sarepta Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,314

Employees1,314

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,314

Employees1,314

SRPT Key Statistics

Market cap

12.17B

Market cap12.17B

Price-Earnings ratio

-20.91

Price-Earnings ratio-20.91

Dividend yield

—

Dividend yield—

Average volume

902.81K

Average volume902.81K

High today

$131.46

High today$131.46

Low today

$125.62

Low today$125.62

Open price

$127.53

Open price$127.53

Volume

953.99K

Volume953.99K

52 Week high

$159.89

52 Week high$159.89

52 Week low

$55.25

52 Week low$55.25

SRPT News

Simply Wall St 2d

Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock

Multiple insiders secured a larger position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares over the last 12 months. This is reassuring as this suggests that...

Benzinga 3d

This Is What Whales Are Betting On Sarepta Therapeutics - Sarepta Therapeutics - Benzinga

Loading... Loading... High-rolling investors have positioned themselves bullish on Sarepta Therapeutics SRPT, and it's important for retail traders to take not...

Yahoo Finance 3d

Sarepta Therapeutics to Announce First Quarter 2024 Financial Results - Yahoo Finance

CAMBRIDGE, Mass., April 24, 2024--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will re...

Analyst ratings

81%

of 21 ratings

Buy

81%

Hold

19%

Sell